HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 21, 15578-15588, May 25, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: 282/21/15578    most recent M607434200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Habuchi, H. Articles by Kimata, K. Search for Related Content PubMed PubMed Citation Articles by Habuchi, H. Articles by Kimata, K. Social Bookmarking                      What's this?

Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1 Exhibit Defective Heparan Sulfate Biosynthesis, Abnormal Placentation, and Late Embryonic Lethality^*

Hiroko Habuchi, Naoko Nagai, Noriko Sugaya, Fukiko Atsumi, Richard L. Stevens^¶, and Koji Kimata¹

From the Institute for Molecular Science of Medicine and Laboratory Animal Research Center, Aichi Medical University, Nagakute, Aichi 480-1195, Japan and the ^¶Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115

Heparan sulfate (HS) plays critical roles in a variety of developmental, physiological, and pathogenic processes due to its ability to interact in a structure-dependent manner with numerous growth factors that participate in cellular signaling. The divergent structures of HS glycosaminoglycans are the result of the coordinate actions of several N- and O-sulfotransferases, C5-epimerase, and 6-O-endosulfatases. We have shown that 6-O-sulfation of the glucosamine residues in HS are catalyzed by the sulfotransferases HS6ST-1, -2, and -3. To determine the biological and physiological importance of HS6ST-1, we now describe the creation of transgenic mice that lack this sulfotransferase. Most of our HS6ST-1-null mice died between embryonic day 15.5 and the perinatal stage, and those mice that survived were considerably smaller than their wild-type littermates. Some of these HS6ST-1-null mice exhibited development abnormalities, and histochemical and molecular analyses of these mice revealed an 50% reduction in the number of fetal microvessels in the labyrinthine zone of the placenta relative to that in the wild-type mice. Because we observed a modest reduction in VEGF-A mRNA and protein in the tissues of HS6ST-1-null mice, an HS-dependent defect in cytokine signaling probably contributes to increased embryonic lethality and decreased growth. Biochemical studies of the HS chains isolated from various organs of our HS6ST-1-null mice revealed a marked reduction of GlcNAc(6SO₄) and HexA-GlcNSO₃(6SO₄) levels and a reduced ability to bind Wnt2. Thus, despite the presence of three closely related 6-O-sulfotransferase genes in the mouse genome, HS6ST-1 is the primary one used in HS biosynthesis in most tissues.

Received for publication, August 4, 2006 , and in revised form, March 27, 2007.

^* This work was supported by a Japan Society for the Promotion of Science grant-in-aid for the promotion of science, by Grants-in-aid for Scientific Research on Priority Areas 14082206 and 17570099 from the Ministry of Education, Culture, Sport, Science, and Technology of Japan, by National Institutes of Health Grant HL036110 (to R. L. S.), and by a special research fund from Seikagaku Corp. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed: Institute for Molecular Science of Medicine, Aichi Medical University, Nagakute, Aichi 480-1195, Japan. Tel.: 81-52-264-4811; Fax: 81-561-63-3532; E-mail: kimata{at}aichi-med-u.ac.jp.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				X. Yue, X. Li, H. T. Nguyen, D. R. Chin, D. E. Sullivan, and J. A. Lasky Transforming Growth Factor-{beta}1 Induces Heparan Sulfate 6-O-Endosulfatase 1 Expression in Vitro and in Vivo J. Biol. Chem., July 18, 2008; 283(29): 20397 - 20407. [Abstract] [Full Text] [PDF]

				Y. Pan, C. Carbe, A. Powers, E. E. Zhang, J. D. Esko, K. Grobe, G.-S. Feng, and X. Zhang Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction Development, January 15, 2008; 135(2): 301 - 310. [Abstract] [Full Text] [PDF]

				T. Kobayashi, H. Habuchi, K. Tamura, H. Ide, and K. Kimata Essential Role of Heparan Sulfate 2-O-Sulfotransferase in Chick Limb Bud Patterning and Development J. Biol. Chem., July 6, 2007; 282(27): 19589 - 19597. [Abstract] [Full Text] [PDF]